{
  "ticker": "BMY",
  "last_updated": "2025-04-15T12:45:33.214155",
  "retention_years": 3,
  "count": 28,
  "transactions": [
    {
      "id": 40483,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "VESSEY RUPERT",
      "reporting_owner_cik": "0001677618",
      "reporting_owner_position": "EVP, Research & Early Dev.",
      "transaction_date": "2022-12-02",
      "transaction_shares": "8792",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "65871"
    },
    {
      "id": 40492,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Elkins David V",
      "reporting_owner_cik": "0001451604",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2022-12-02",
      "transaction_shares": "8792",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "128578"
    },
    {
      "id": 40508,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "BOERNER CHRISTOPHER S.",
      "reporting_owner_cik": "0001543747",
      "reporting_owner_position": "EVP, Chief Commercial Officer",
      "transaction_date": "2022-12-02",
      "transaction_shares": "2637",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "44603"
    },
    {
      "id": 40491,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Powell Ann",
      "reporting_owner_cik": "0001570844",
      "reporting_owner_position": "EVP, Chief Human Resources",
      "transaction_date": "2022-11-09",
      "transaction_shares": "16250",
      "transaction_price": "80.45",
      "transaction_type": "S",
      "shares_after_transaction": "34226.088"
    },
    {
      "id": 40511,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "VESSEY RUPERT",
      "reporting_owner_cik": "0001677618",
      "reporting_owner_position": "EVP, Research & Early Dev.",
      "transaction_date": "2022-11-07",
      "transaction_shares": "5843",
      "transaction_price": "70.89",
      "transaction_type": "M",
      "shares_after_transaction": "56228"
    },
    {
      "id": 20450,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Caforio Giovanni",
      "reporting_owner_cik": "0001533201",
      "reporting_owner_position": "Board Chair and CEO",
      "transaction_date": "2022-09-20",
      "transaction_shares": "25000",
      "transaction_price": "69.71",
      "transaction_type": "S",
      "shares_after_transaction": "476104.333"
    },
    {
      "id": 40485,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Caforio Giovanni",
      "reporting_owner_cik": "0001533201",
      "reporting_owner_position": "Board Chair and CEO",
      "transaction_date": "2022-09-20",
      "transaction_shares": "25000",
      "transaction_price": "69.71",
      "transaction_type": "S",
      "shares_after_transaction": "476104.333"
    },
    {
      "id": 20445,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Caforio Giovanni",
      "reporting_owner_cik": "0001533201",
      "reporting_owner_position": "Board Chair and CEO",
      "transaction_date": "2022-09-15",
      "transaction_shares": "50000",
      "transaction_price": "71.84",
      "transaction_type": "S",
      "shares_after_transaction": "501104.333"
    },
    {
      "id": 40475,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Caforio Giovanni",
      "reporting_owner_cik": "0001533201",
      "reporting_owner_position": "Board Chair and CEO",
      "transaction_date": "2022-09-15",
      "transaction_shares": "50000",
      "transaction_price": "71.84",
      "transaction_type": "S",
      "shares_after_transaction": "501104.333"
    },
    {
      "id": 20459,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Powell Ann",
      "reporting_owner_cik": "0001570844",
      "reporting_owner_position": "EVP, Chief Human Resources",
      "transaction_date": "2022-09-14",
      "transaction_shares": "25000",
      "transaction_price": "70.75",
      "transaction_type": "S",
      "shares_after_transaction": "50476.088"
    },
    {
      "id": 40497,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Powell Ann",
      "reporting_owner_cik": "0001570844",
      "reporting_owner_position": "EVP, Chief Human Resources",
      "transaction_date": "2022-09-14",
      "transaction_shares": "25000",
      "transaction_price": "70.75",
      "transaction_type": "S",
      "shares_after_transaction": "50476.088"
    },
    {
      "id": 20468,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Elkins David V",
      "reporting_owner_cik": "0001451604",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2022-09-13",
      "transaction_shares": "30000",
      "transaction_price": "71.35",
      "transaction_type": "S",
      "shares_after_transaction": "100460"
    },
    {
      "id": 40509,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Elkins David V",
      "reporting_owner_cik": "0001451604",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2022-09-13",
      "transaction_shares": "30000",
      "transaction_price": "71.35",
      "transaction_type": "S",
      "shares_after_transaction": "100460"
    },
    {
      "id": 7264,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hirawat Samit",
      "reporting_owner_cik": "0001781290",
      "reporting_owner_position": "EVP,Chief Med.Offr.,Drug Dev.",
      "transaction_date": "2022-07-01",
      "transaction_shares": "9356",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "26078"
    },
    {
      "id": 7269,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Weese Michelle",
      "reporting_owner_cik": "0001867715",
      "reporting_owner_position": "EVP, Corporate Affairs",
      "transaction_date": "2022-07-01",
      "transaction_shares": "1885",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "1885"
    },
    {
      "id": 20452,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hirawat Samit",
      "reporting_owner_cik": "0001781290",
      "reporting_owner_position": "EVP,Chief Med.Offr.,Drug Dev.",
      "transaction_date": "2022-07-01",
      "transaction_shares": "9356",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "26078"
    },
    {
      "id": 20461,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Weese Michelle",
      "reporting_owner_cik": "0001867715",
      "reporting_owner_position": "EVP, Corporate Affairs",
      "transaction_date": "2022-07-01",
      "transaction_shares": "1885",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "1885"
    },
    {
      "id": 40487,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hirawat Samit",
      "reporting_owner_cik": "0001781290",
      "reporting_owner_position": "EVP,Chief Med.Offr.,Drug Dev.",
      "transaction_date": "2022-07-01",
      "transaction_shares": "9356",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "26078"
    },
    {
      "id": 40499,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Weese Michelle",
      "reporting_owner_cik": "0001867715",
      "reporting_owner_position": "EVP, Corporate Affairs",
      "transaction_date": "2022-07-01",
      "transaction_shares": "1885",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "1885"
    },
    {
      "id": 7263,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Caforio Giovanni",
      "reporting_owner_cik": "0001533201",
      "reporting_owner_position": "Board Chair and CEO",
      "transaction_date": "2022-06-13",
      "transaction_shares": "30000",
      "transaction_price": "74.04",
      "transaction_type": "S",
      "shares_after_transaction": "551104.333"
    },
    {
      "id": 20451,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Caforio Giovanni",
      "reporting_owner_cik": "0001533201",
      "reporting_owner_position": "Board Chair and CEO",
      "transaction_date": "2022-06-13",
      "transaction_shares": "30000",
      "transaction_price": "74.04",
      "transaction_type": "S",
      "shares_after_transaction": "551104.333"
    },
    {
      "id": 40486,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Caforio Giovanni",
      "reporting_owner_cik": "0001533201",
      "reporting_owner_position": "Board Chair and CEO",
      "transaction_date": "2022-06-13",
      "transaction_shares": "30000",
      "transaction_price": "74.04",
      "transaction_type": "S",
      "shares_after_transaction": "551104.333"
    },
    {
      "id": 7274,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "LEUNG SANDRA",
      "reporting_owner_cik": "0001199294",
      "reporting_owner_position": "EVP, General Counsel",
      "transaction_date": "2022-06-06",
      "transaction_shares": "65000",
      "transaction_price": "74.89",
      "transaction_type": "S",
      "shares_after_transaction": "308627.333"
    },
    {
      "id": 20470,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "LEUNG SANDRA",
      "reporting_owner_cik": "0001199294",
      "reporting_owner_position": "EVP, General Counsel",
      "transaction_date": "2022-06-06",
      "transaction_shares": "65000",
      "transaction_price": "74.89",
      "transaction_type": "S",
      "shares_after_transaction": "308627.333"
    },
    {
      "id": 40513,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "LEUNG SANDRA",
      "reporting_owner_cik": "0001199294",
      "reporting_owner_position": "EVP, General Counsel",
      "transaction_date": "2022-06-06",
      "transaction_shares": "65000",
      "transaction_price": "74.89",
      "transaction_type": "S",
      "shares_after_transaction": "308627.333"
    },
    {
      "id": 7272,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Haller Julia A",
      "reporting_owner_cik": "0001656082",
      "reporting_owner_position": null,
      "transaction_date": "2022-06-03",
      "transaction_shares": "2949",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "13619"
    },
    {
      "id": 20467,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Haller Julia A",
      "reporting_owner_cik": "0001656082",
      "reporting_owner_position": null,
      "transaction_date": "2022-06-03",
      "transaction_shares": "2949",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "13619"
    },
    {
      "id": 40507,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Haller Julia A",
      "reporting_owner_cik": "0001656082",
      "reporting_owner_position": null,
      "transaction_date": "2022-06-03",
      "transaction_shares": "2949",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "13619"
    }
  ]
}